| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | 11,951,714 | $13,152,861 | $1.10 | 21 Jan 2026 | Indirect Beneficial Ownership in the 11,951,714 owned by Daewoong Pharmaceutical Co., Ltd | ||
| Common Stock, $0.0001 par value per share | 58,023 | $63,854 | $1.10 | 21 Jan 2026 | Direct |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|